Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Drospirenone/estetrol - Mithra Pharmaceuticals

Drug Profile

Drospirenone/estetrol - Mithra Pharmaceuticals

Alternative Names: DRSP/E4; E4/DRSP; Estelle; Estetrol/Drospirenone; FSN-013

Latest Information Update: 31 Dec 2018

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Estetra S.A.
  • Developer Estetra S.A.; Fuji Pharmaceutical
  • Class Androstenes; Anti-inflammatories; Antiandrogens; Antimigraines; Antineoplastics; Gonadal steroid hormones; Hormonal replacements; Oral contraceptives; Progesterone congeners; Small molecules
  • Mechanism of Action Estrogen receptor agonists; Mineralocorticoid receptor antagonists; Progesterone receptor agonists; Testosterone congener inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No
  • Available For Licensing Yes

Highest Development Phases

  • Phase III Pregnancy

Most Recent Events

  • 07 Jan 2019 Mithra Pharmaceuticals anticipates to launch PeriNesta by the end of 2023
  • 06 Dec 2018 Efficacy and adverse events data from a sub-study trial in Pregnancy (Prevention) released by Mithra Pharmaceuticals
  • 14 Nov 2018 Mithra Pharmaceuticals completes the phase III E4 FREEDOM trial in Pregnancy (Prevention) in USA and Canada
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top